Publication: Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome.
No Thumbnail Available
Date
2020-07-08, 2020.01.01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrikler
Total Views
0
Total Downloads
0
Abstract
To compare the efficacy of bevacizumab, ranibizumab, and aflibercept in pseudophakic cystoid macular edema (CME) patients with Irvine-Gass syndrome (IGS).
Description
Keywords
Irvine-Gass syndrome